Adtalem Global Education (NYSE:CVSA) CFO Robert Phelan Sells 2,186 Shares of Stock

Adtalem Global Education Inc. (NYSE:CVSA) CFO Robert Phelan sold 2,186 shares of the stock in a transaction on Friday, August 7th. The shares were sold at an average price of $135.15, for a total value of $295,437.90. Following the sale, the chief financial officer owned 48,306 shares in the company, valued at $6,528,555.90. The trade was a 4.33% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Down 2.1%

NYSE CVSA opened at $125.98 on Wednesday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09. The stock’s fifty day moving average price is $124.90. The stock has a market capitalization of $4.29 billion, a price-to-earnings ratio of 17.89, a price-to-earnings-growth ratio of 0.95 and a beta of 0.62. Adtalem Global Education Inc. has a 52 week low of $86.97 and a 52 week high of $156.26.

Adtalem Global Education (NYSE:CVSA) last announced its earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.19. The business had revenue of $501.38 million for the quarter. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Equities research analysts anticipate that Adtalem Global Education Inc. will post 8.99 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CVSA. Truist Financial raised their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Wall Street Zen raised Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Finally, Barrington Research reissued an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a research note on Monday, June 8th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Adtalem Global Education has an average rating of “Moderate Buy” and a consensus price target of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.